Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Qualifyze has introduced the Quality Insights Platform, an AI-driven tool designed to enhance supplier site risk management for the pharmaceutical industry, announced in a press release.
Diagnostics.ai has introduced the first CE-IVDR certified AI platform for molecular diagnostics, offering transparency and compliance with EU regulations.
Minset has announced a seed funding round led by HealthX Ventures to scale its AI platform for healthcare revenue cycle management.
Biotia's BIOTIA-DX Resistance tool achieved the highest prediction accuracy at the CAMDA 2025 Antimicrobial Resistance Challenge, showcasing its advanced capabilities in genomics and AI.
Retrieve Medical Holdings and MyID have announced a joint venture to introduce the first wearable device with a complete electronic health record, combining AI technology with wearable tech.
PhaseV has announced a partnership with the Crohn's & Colitis Foundation to enhance IBD research using AI and machine learning, as stated in a press release.
Novellia has announced Project EVEREST, an AI-powered initiative to enhance breast cancer treatment adherence, supported by Daiichi Sankyo, Genentech, and AstraZeneca.
Arkstone Medical Solutions has published a study demonstrating the effectiveness of its AI-driven clinical decision support system in treating bacteremia, reducing treatment recommendation time by 29 hours.
CorePlus Puerto Rico has published a study validating the use of AI and whole slide imaging for 100% quality control in cervical cytology, as announced in a press release.
Sectra has signed a five-year contract to supply a US health system with its cloud-based enterprise imaging solution, Sectra One Cloud, and AI service, Sectra Amplifier Service.
Samsung Ventures is considering a significant investment in Exo, a California-based startup specializing in portable ultrasound devices, as part of a $100 million funding round led by Sands Capital, Bold Capital, and Qubit Health Capital.
QI Path has launched a new AI-driven risk governance platform designed to enhance risk mitigation and regulatory readiness in the life sciences industry, announced in a press release.
Avant Technologies and Ainnova Tech are exploring the integration of early dementia detection into their AI-powered screening platform, Vision AI.
Veeva Systems will host the Veeva R&D and Quality Summit in Madrid, featuring keynotes from industry leaders like Bayer and Novo Nordisk.
AI Medical Technology has received CE mark approval for Dermalyser, a smartphone-based melanoma detection tool, allowing its commercial launch across Europe.
Lunit will present 12 studies at the ASCO 2025 Annual Meeting, highlighting AI's role in precision oncology, including HER2 analysis in biliary tract cancer and PD-L1 evaluation in lung cancer.
MindHYVE.ai has partnered with Islamabad Diagnostic Centre to deploy AGI-powered diagnostic agents across Pakistan, enhancing clinical diagnostics with AI technology.
Perimeter Medical Imaging AI has partnered with Intermountain Health to study the benefits of using OCT and AI in reducing cancer reoperations, announced in a press release.
GATC Health Corp has published a paper detailing how its AI-driven Multiomics Advanced Technology platform enhances drug discovery by improving efficiency and reducing animal testing.
The American Society of Clinical Oncology (ASCO) and Google Cloud have announced a collaboration to launch an AI-based tool for accessing ASCO's clinical guidelines, enhancing oncology professionals' decision-making capabilities.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
